{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:18:22Z","timestamp":1759335502491,"version":"3.37.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T00:00:00Z","timestamp":1618444800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T00:00:00Z","timestamp":1618444800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Carl von Ossietzky Universit\u00e4t Oldenburg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Fam Pract"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The primary objective was to describe outpatient treatment of epistaxis among different physicians based on a large patient population over a period of 10 years. The secondary objective was to evaluate the value of the practice fee as an instrument of allocation in patients with epistaxis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Anonymized statutory health insurance data (AOK Lower Saxony) of patients with a diagnosis of epistaxis treated between 2007 and 2016 were examined. Demographic data, accompanying diagnoses, medication and involved medical groups (general practitioners (GP), pediatricians, ear, nose and throat (ENT) specialists or other) were analyzed. Furthermore, we assessed whether the use of specialist groups changed after abolition of the practice fee in 2013.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Epistaxis was responsible for 302,782 cases (160,963 patients). The distribution of cases was slightly in favor of ENT specialists vs. GP (119,170 vs. 110,352). The cases seen by GP and ENT specialists were comparable with regard to age and sex distribution. Hypertension, atrial fibrillation\/flutter and an antithrombotic therapy were slightly more common among cases consulting a GP. The GP recorded more co-diagnoses than the ENT. The use of outpatient care and the proportions of the involved physicians scarcely fluctuated during the study period. Overall, 23,118 patients (14.4%) were diagnosed by both, GP and ENT during a relatively short time period. The practice fee remuneration had no impact on the consultation of the physician groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The outpatient treatment of epistaxis constitutes a considerable medical and economic burden in Germany. Strengthening the primary medical sector (GP-centered care) is necessary to reach the goal of initially directing patients to primary care, providing specialists more time for severe cases and reducing the impact on public health balance sheets.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12875-021-01411-1","type":"journal-article","created":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T16:03:24Z","timestamp":1618502604000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Treating epistaxis \u2013 who cares for a bleeding nose? A secondary data analysis of primary and secondary care"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3950-3863","authenticated-orcid":false,"given":"Annina E.","family":"Althaus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas","family":"L\u00fcske","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrike","family":"Arendt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"D\u00f6rks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael H.","family":"Freitag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Falk","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathrin","family":"Jobski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,15]]},"reference":[{"issue":"3","key":"1411_CR1","first-page":"129","volume":"13","author":"B Petruson","year":"1975","unstructured":"Petruson B, Rudin R. The frequency of epistaxis in a male population sample. Rhinology. 1975;13(3):129\u201333.","journal-title":"Rhinology"},{"issue":"1","key":"1411_CR2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.annemergmed.2004.12.014","volume":"46","author":"DJ Pallin","year":"2005","unstructured":"Pallin DJ, et al. Epidemiology of epistaxis in US emergency departments, 1992 to 2001. Ann Emerg Med. 2005;46(1):77\u201381.","journal-title":"Ann Emerg Med"},{"key":"1411_CR3","doi-asserted-by":"publisher","DOI":"10.1787\/reg_glance-2013-en","volume-title":"Health at a glance 2013: OECD indicators","author":"OECD","year":"2013","unstructured":"OECD. Health at a glance 2013: OECD indicators. 2013."},{"key":"1411_CR4","doi-asserted-by":"publisher","DOI":"10.1787\/b6d3dcfc-en","volume-title":"Health at a glance 2019","author":"OECD","year":"2019","unstructured":"OECD. Health at a glance 2019. 2019."},{"issue":"5","key":"1411_CR5","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/S0196-0644(95)70169-9","volume":"25","author":"RA Viducich","year":"1995","unstructured":"Viducich RA, Blanda MP, Gerson LW. Posterior epistaxis: clinical features and acute complications. Ann Emerg Med. 1995;25(5):592\u20136.","journal-title":"Ann Emerg Med"},{"issue":"3","key":"1411_CR6","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.joms.2005.11.031","volume":"64","author":"TL Viehweg","year":"2006","unstructured":"Viehweg TL, Roberson JB, Hudson JW. Epistaxis: diagnosis and treatment. J Oral Maxillofac Surg. 2006;64(3):511\u20138.","journal-title":"J Oral Maxillofac Surg"},{"key":"1411_CR7","unstructured":"OECD, E.O.o.H. Systems, and policies, Germany: Country Health Profile 2019. 2019."},{"key":"1411_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-540-73042-2_32","volume-title":"Einfluss der Einf\u00fchrung der Praxisgeb\u00fchr auf Art und Umfang der ambulanten Versorgung der Hypertonie","author":"U Maywald","year":"2008","unstructured":"Maywald U, Fuchs A. Einfluss der Einf\u00fchrung der Praxisgeb\u00fchr auf Art und Umfang der ambulanten Versorgung der Hypertonie. Berlin: Springer Berlin Heidelberg; 2008."},{"key":"1411_CR9","volume-title":"Zeigt die Praxisgeb\u00fchr die gew\u00fcnschte Wirkung?","author":"T Bauer","year":"2007","unstructured":"Bauer T, Augurzky B, Schaffner S. Zeigt die Praxisgeb\u00fchr die gew\u00fcnschte Wirkung? 2007."},{"issue":"1\u201302","key":"1411_CR10","first-page":"12","volume":"115","author":"R Beck","year":"2018","unstructured":"Beck R, et al. Current approaches to epistaxis treatment in primary and secondary care. Dtsch Arztebl Int. 2018;115(1\u201302):12\u201322.","journal-title":"Dtsch Arztebl Int"},{"key":"1411_CR11","unstructured":"Bundesgesundheitsministerium. Mitglieder und Versicherte der Gesetzlichen Krankenversicherung (GKV): Statistik \u00fcber Versicherte, gegliedert nach Status, Alter, Wohnort und Kassenart (Stichtag: 1. Juli des jeweiligen Jahres). 2016 www.bundesgesundheitsministerium.de\/themen\/krankenversicherung\/zahlen-und-fakten-zur-krankenversicherung\/mitglieder-und-versicherte.html. 4 Mar 2020."},{"issue":"3","key":"1411_CR12","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/s00106-020-00940-y","volume":"69","author":"AE Althaus","year":"2020","unstructured":"Althaus AE, et al. [Epistaxis and anticoagulation therapy: an analysis based on health insurance data from Lower Saxony]. HNO. 2020;69(3):206\u201312.","journal-title":"HNO"},{"issue":"6","key":"1411_CR13","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1136\/adc.2008.144881","volume":"94","author":"S Paranjothy","year":"2009","unstructured":"Paranjothy S, et al. The incidence and aetiology of epistaxis in infants: a population-based study. Arch Dis Child. 2009;94(6):421\u20134.","journal-title":"Arch Dis Child"},{"issue":"8","key":"1411_CR14","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.ijporl.2014.05.013","volume":"78","author":"K Davies","year":"2014","unstructured":"Davies K, et al. Pediatric epistaxis: epidemiology, management & impact on quality of life. Int J Pediatr Otorhinolaryngol. 2014;78(8):1294\u20137.","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"6","key":"1411_CR15","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.otorri.2017.11.002","volume":"69","author":"LR Reis","year":"2018","unstructured":"Reis LR, et al. Epidemiology of epistaxis in the emergency department of a southern European tertiary care hospital. Acta Otorrinolaringol Esp. 2018;69(6):331\u20138.","journal-title":"Acta Otorrinolaringol Esp"},{"issue":"6","key":"1411_CR16","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1111\/coa.13178","volume":"43","author":"CM Douglas","year":"2018","unstructured":"Douglas CM, et al. Patterns of hospital admission in 54 501 patients with epistaxis over a 20-year period in Scotland, UK. Clin Otolaryngol. 2018;43(6):1465\u201370.","journal-title":"Clin Otolaryngol"},{"issue":"8","key":"1411_CR17","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1308\/003588412X13373405386691","volume":"94","author":"SJ Fishpool","year":"2012","unstructured":"Fishpool SJ, Tomkinson A. Patterns of hospital admission with epistaxis for 26,725 patients over an 18-year period in Wales, UK. Ann R Coll Surg Engl. 2012;94(8):559\u201362.","journal-title":"Ann R Coll Surg Engl"},{"issue":"1","key":"1411_CR18","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12875-019-0929-4","volume":"20","author":"I Seeger","year":"2019","unstructured":"Seeger I, et al. Cross-sectional study in an out-of-hours primary care Centre in northwestern Germany - patient characteristics and the urgency of their treatment. BMC Fam Pract. 2019;20(1):41.","journal-title":"BMC Fam Pract"},{"key":"1411_CR19","volume-title":"Modalit\u00e4ten und Effekte von Zuzahlungen im Gesundheitswesen","author":"J Holst","year":"2004","unstructured":"Holst J. Modalit\u00e4ten und Effekte von Zuzahlungen im Gesundheitswesen. Frankfurt am Main: Zentrum der Psychosozialen Grundlagen der Medizin, Klinikum der Johann Wolfgang Goethe-Universit\u00e4t; 2004."},{"key":"1411_CR20","volume-title":"Zuzahlungen nach dem GKV-Modernisierungsgesetz (GMG) unter Ber\u00fccksichtigung von H\u00e4rtefallregelungen, in Volkswirtschaftliche Diskussionsreihe","author":"A Kern","year":"2003","unstructured":"Kern A. Zuzahlungen nach dem GKV-Modernisierungsgesetz (GMG) unter Ber\u00fccksichtigung von H\u00e4rtefallregelungen, in Volkswirtschaftliche Diskussionsreihe. Augsburg: Institut f\u00fcr Volkswirtschaftslehre Universit\u00e4t Augsburg; 2003."},{"issue":"12","key":"1411_CR21","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1377\/hlthaff.2013.0879","volume":"32","author":"C Schoen","year":"2013","unstructured":"Schoen C, et al. Access, affordability, and insurance complexity are often worse in the United States compared to ten other countries. Health Aff. 2013;32(12):2205\u201315.","journal-title":"Health Aff"},{"key":"1411_CR22","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/978-3-642-23499-6_460","volume-title":"Encyclopedia of otolaryngology, head and neck surgery","author":"JB Chafin","year":"2013","unstructured":"Chafin JB, Gauger C, Josephson GD. Epistaxis in pediatric patient. In: Kountakis SE, editor. Encyclopedia of otolaryngology, head and neck surgery. Berlin: Springer Berlin Heidelberg; 2013. p. 805\u201314."},{"key":"1411_CR23","unstructured":"Deutsche Gesellschaft f\u00fcr Allgemeinmedizin und Familienmedizin, D. [1 Jun 2020]; Available from: https:\/\/www.degam.de\/fachdefinition.html."},{"issue":"6","key":"1411_CR24","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1111\/j.1365-2273.2004.00922.x","volume":"29","author":"EC Ho","year":"2004","unstructured":"Ho EC, Mansell NJ. How we do it: a practical approach to Foley catheter posterior nasal packing. Clin Otolaryngol Allied Sci. 2004;29(6):754\u20137.","journal-title":"Clin Otolaryngol Allied Sci"},{"issue":"4","key":"1411_CR25","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1136\/emj.10.4.298","volume":"10","author":"GW McGarry","year":"1993","unstructured":"McGarry GW, Moulton C. The first aid management of epistaxis by accident and emergency department staff. Arch Emerg Med. 1993;10(4):298\u2013300.","journal-title":"Arch Emerg Med"},{"issue":"1","key":"1411_CR26","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1258\/0022215053222752","volume":"119","author":"HL Beer","year":"2005","unstructured":"Beer HL, et al. Blood loss estimation in epistaxis scenarios. J Laryngol Otol. 2005;119(1):16\u20138.","journal-title":"J Laryngol Otol"},{"issue":"4","key":"1411_CR27","first-page":"249","volume":"93","author":"C Bermuller","year":"2014","unstructured":"Bermuller C, et al. [Epistaxis and anticoagulation - a medical and economic challenge?] Laryngorhinootologie. 2014;93(4):249\u201355.","journal-title":"Laryngorhinootologie"},{"key":"1411_CR28","unstructured":"Kassen\u00e4rztlichen Bundesvereinigung. Deutschlandweite Projektion 2030 - Arztzahlentwicklung in Deutschland 2016 https:\/\/www.kbv.de\/media\/sp\/2016_10_05_Projektion_2030_Arztzahlentwicklung.pdf. Accessed 17 Sept 2020."},{"key":"1411_CR29","unstructured":"Muehlbacher A. 2020 [30 Mar 2020]; Available from: https:\/\/wirtschaftslexikon.gabler.de\/definition\/hausarztzentrierte-versorgung-gatekeeping-51769."},{"issue":"2","key":"1411_CR30","doi-asserted-by":"publisher","first-page":"201","DOI":"10.2190\/8WMP-RR2K-ABM7-NVNH","volume":"24","author":"RB Saltman","year":"1994","unstructured":"Saltman RB. Patient choice and patient empowerment in northern European health systems: a conceptual framework. Int J Health Serv. 1994;24(2):201\u201329.","journal-title":"Int J Health Serv"},{"issue":"8\u20139","key":"1411_CR31","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1055\/s-0029-1234126","volume":"72","author":"A Zentner","year":"2010","unstructured":"Zentner A, Velasco Garrido M, Busse R. [Do primary care physicians acting as gatekeepers really improve health outcomes and decrease costs? A systematic review of the concept gatekeeping]. Gesundheitswesen. 2010;72(8\u20139):e38\u201344.","journal-title":"Gesundheitswesen"},{"issue":"1","key":"1411_CR32","first-page":"e1","volume":"79","author":"F Hoffmann","year":"2017","unstructured":"Hoffmann F, Koller D. [Different regions, differently insured populations? Socio-demographic and health-related differences between insurance funds]. Gesundheitswesen. 2017;79(1):e1\u20139.","journal-title":"Gesundheitswesen"}],"container-title":["BMC Family Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-021-01411-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12875-021-01411-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-021-01411-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T16:04:09Z","timestamp":1618502649000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcfampract.biomedcentral.com\/articles\/10.1186\/s12875-021-01411-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,15]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1411"],"URL":"https:\/\/doi.org\/10.1186\/s12875-021-01411-1","relation":{},"ISSN":["1471-2296"],"issn-type":[{"type":"electronic","value":"1471-2296"}],"subject":[],"published":{"date-parts":[[2021,4,15]]},"assertion":[{"value":"16 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"\u00a0As the article used anonymized secondary data, patient-informed consent was not required by German regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"75"}}